Showing 1 - 10 of 584
Persistent link: https://www.econbiz.de/10003537870
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several...
Persistent link: https://www.econbiz.de/10011337697
Individuals should be entitled to a "fair innings", and the primary role of health systems should be the prevention of premature mortality. In India, 66 percent of all deaths are premature. The burden of premature mortality has shifted from child (0-5 years) to adult (30-69 years) level over the...
Persistent link: https://www.econbiz.de/10011477283
The rising burden of disease counts as one of the most salient concerns of a warming climate. These risks are especially serious in populous, rapidly growing urban landscapes of low-income, tropical countries. Surat, located on the banks of the River Tapi, has temperature and humidity patterns...
Persistent link: https://www.econbiz.de/10011994124
Persistent link: https://www.econbiz.de/10013545964
Persistent link: https://www.econbiz.de/10014282086
Persistent link: https://www.econbiz.de/10014283466
Persistent link: https://www.econbiz.de/10014549674
Persistent link: https://www.econbiz.de/10003514303